UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 72 filers reported holding UROGEN PHARMA LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $860,000 | – | 18,200 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,252,285 | $24,156,000 | 7.72% |
| Horton Capital Management, LLC | 375,428 | $7,242,000 | 6.96% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $56,996,000 | 1.27% |
| Phoenix Holdings Ltd. | 901,979 | $16,405,000 | 0.69% |
| SHIKIAR ASSET MANAGEMENT INC | 44,550 | $859,000 | 0.33% |
| Coastal Bridge Advisors, LLC | 37,000 | $714,000 | 0.22% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $14,242,000 | 0.20% |
| Clal Insurance Enterprises Holdings Ltd | 529,388 | $10,212,000 | 0.17% |
| Vivaldi Capital Management LP | 10,000 | $233,000 | 0.05% |
| MEITAV INVESTMENT HOUSE LTD | 48,407 | $934,000 | 0.05% |